Back to Search Start Over

Congenital hypogonadotropic hypogonadism complicated by neuroblastoma.

Authors :
Yukiko Ueta
Keiko Aso
Youichi Haga
Hiroyuki Takahashi
Mari Satoh
Source :
Clinical Pediatric Endocrinology. 2022, Vol. 31 Issue 3, p159-162. 4p.
Publication Year :
2022

Abstract

A 3-mo-old male infant was referred to our hospital with micropenis. Since his serum LH, FSH, and testosterone levels were low (< 0.3 mIU/mL, 0.08 mIU/mL, and < 0.03 ng/mL, respectively), Kallmann syndrome/ normosmic hypogonadotropic hypogonadism was suspected. In the process of searching for complications of Kallmann syndrome/normosmic hypogonadotropic hypogonadism, a right adrenal gland tumor was incidentally discovered. The patient was diagnosed with stage 1 neuroblastoma. A homozygous p.P147L (c.C440T) mutation in the KISS1R gene was detected as a cause of the congenital hypogonadotropic hypogonadism. KISS1-KISS1R signaling, which is essential for GnRH secretion, exhibits anti-metastatic and/or anti-tumoral roles in numerous cancers. High KISS1 expression levels reportedly predict better survival outcomes than low KISS1 expression levels in neuroblastoma. Therefore, decreased KISS1-KISS1R signaling may have played a role in the neuroblastoma in this patient. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09185739
Volume :
31
Issue :
3
Database :
Academic Search Index
Journal :
Clinical Pediatric Endocrinology
Publication Type :
Academic Journal
Accession number :
158461272
Full Text :
https://doi.org/10.1297/cpe.2021-0070